Merck logo

2027 Future Talent Program - Payer & Health Systems Oncology - Intern

Merck

North Wales, PARemotePosted 2 days ago$39,908 - $111,111
InternshipInternMedical AffairsPharmaceutical
Original posting ↗

Summary

The Future Talent Program features internships that last up to 12 weeks and will include one or more projects. The Payer and Health Systems (PHS) team is seeking a motivated and collaborative 2027 summer intern for a 10-12 week internship to support strategic initiatives focused on oncology, patient access, health systems, and medical affairs.

Job description

Primary Responsibilities

  • Support development and refinement of health system and payer insight-gathering priorities.
  • Analyze and summarize stakeholder insights and identify trends across the oncology landscape.
  • Evaluate payer policy, reimbursement, quality, pathway, and regulatory developments affecting oncology care.
  • Contribute to field engagement planning resources and internal training materials.
  • Collaborate with cross-functional Medical Affairs stakeholders.
  • Develop and present findings for project assignments with recommendations to PHS leadership.

Learning Objectives

  • Understand the role of U.S. Medical Affairs payer and health system access team within the pharmaceutical industry.
  • Gain exposure to payer and health-system decision-making in oncology.
  • Learn how stakeholder insights inform medical strategy.
  • Strengthen analytical, communication, and project management skills.

Requirements

  • Currently pursuing a PharmD, MD, DNP, or other doctoral-level clinical or health sciences degree and returning to school following the internship
  • Strong verbal and written communication skills
  • Strong organizational and project management skills
  • Ability to manage multiple priorities and meet deadlines
  • Ability to work collaboratively in cross-functional teams
  • Proficiency with Microsoft Office applications

Company overview

Merck & Co., Inc., known as Merck in the United States and Canada and MSD (Merck Sharp & Dohme) internationally, is a premier American multinational pharmaceutical company headquartered in Rahway, New Jersey. Founded in 1891 as the U.S. subsidiary of the German Merck Group, the company became independent following World War I and has since grown into one of the world's largest biomedical companies, ranking fourth globally by revenue. Merck operates across three core business segments: pharmaceuticals, vaccines, and animal health products. The company is renowned for its groundbreaking research and development, having brought numerous life-saving medicines to market including Keytruda (pembrolizumab), a leading immunotherapy for cancer treatment that generated $29.5 billion in 2024 revenue, and Gardasil, a revolutionary HPV vaccine. With approximately 75,000 employees worldwide, Merck maintains a robust pipeline of innovative therapies focused on oncology, vaccines, hospital acute care, cardiology, neuroscience, virology, immunology, and diabetes. The company invests heavily in R&D, spending $17.9 billion in 2024 alone, demonstrating its commitment to advancing scientific discovery. Merck's legacy spans over 130 years of bringing hope to humanity through important medicines and vaccines, operating with a purpose to use leading-edge science to save and improve lives globally while fostering an inclusive workforce and responsible business practices.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.